These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11266201)

  • 1. Torsade de pointes induced by intravenous and long-term oral amiodarone therapy in a patient with dilated cardiomyopathy.
    Yamada S; Kuga K; Yamaguchi I
    Jpn Circ J; 2001 Mar; 65(3):236-8. PubMed ID: 11266201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone-induced torsade de pointes in a child with dilated cardiomyopathy.
    Silvetti MS; Drago F; Bevilacqua M; Ragonese P
    Ital Heart J; 2001 Mar; 2(3):231-6. PubMed ID: 11305536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QTc prolongation and torsades de pointes due to a coadministration of fluoxetine and amiodarone in a patient with implantable cardioverter-defibrillator: Case report and review of the literature.
    Wei A; Peng J; Gu Z; Li J
    Medicine (Baltimore); 2017 Dec; 96(49):e9071. PubMed ID: 29245320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.
    van Opstal JM; Schoenmakers M; Verduyn SC; de Groot SH; Leunissen JD; van Der Hulst FF; Molenschot MM; Wellens HJ; Vos MA
    Circulation; 2001 Nov; 104(22):2722-7. PubMed ID: 11723026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
    Makai A; Rudas L; Liszkai G; Fazekas T
    Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torsade de pointes tachycardia in a patient on dronedarone therapy.
    Huemer M; Sarganas G; Bronder E; Klimpel A; Garbe E; Haverkamp W
    Pharmacotherapy; 2015 May; 35(5):e61-5. PubMed ID: 25823967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
    Skanes AC; Morton BC; Green MS; Tang AS
    Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone-induced torsade de pointes in a patient with wolff-Parkinson-White syndrome.
    Badshah A; Mirza B; Janjua M; Nair R; Steinman RT; Cotant JF
    Hellenic J Cardiol; 2009; 50(3):224-6. PubMed ID: 19465366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
    Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsades de pointes and QT prolongation due to a combination of loratadine and amiodarone.
    Atar S; Freedberg NA; Antonelli D; Rosenfeld T
    Pacing Clin Electrophysiol; 2003 Mar; 26(3):785-6. PubMed ID: 12698686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of amiodarone-induced torsade de pointes by landiolol in a patient with atrial fibrillation-mediated cardiomyopathy.
    Takahashi K; Yamashita M; Sakaue T; Enomoto D; Uemura S; Okura T; Ikeda S; Takemoto M; Utsunomiya Y; Hyodo T
    Ann Noninvasive Electrocardiol; 2021 Nov; 26(6):e12842. PubMed ID: 33755267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TORSADES DE POINTES IN ELDERLY PATIENT WITH PAROXYSMAL ATRIAL FIBRILLATION TREATED BY SHORT-TERM PARENTERAL AMIODARONE THERAPY.
    Lakušić N; Slivnjak V; Ciglenečki N; Cerovec D
    Acta Clin Croat; 2019 Dec; 58(4):751-756. PubMed ID: 32665746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone.
    Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F
    Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torsade de pointes occurring early during oral amiodarone treatment.
    Faggiano P; Gardini A; D'Aloia A; Benedini G; Giordano A
    Int J Cardiol; 1996 Jul; 55(2):205-8. PubMed ID: 8842793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torsade de pointes in initiating hemodialysis: a case report.
    Yang JA; Choi HS; Bae EH; Ma SK; Kim SW; Kim CS
    Ann Palliat Med; 2020 May; 9(3):1264-1268. PubMed ID: 32389016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Torsade de pointes induced by intravenous amiodarone therapy accompanied by marked augmentation of the transmural dispersion of repolarization in a patient with tachycardia-induced-cardiomyopathy.
    Yonai R; Kawabata M; Maeda S; Kawashima T; Tsuda Y; Nakasone T; Nakane H; Hirao K
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12810. PubMed ID: 33070441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent QT prolongation induced by short-term oral amiodarone therapy.
    Astarcioglu MA; Durmuş HI; Sen T; Amasyalı B
    Kardiol Pol; 2014; 72(2):200-1. PubMed ID: 24604507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torsade de pointes induced by short-term oral amiodarone therapy.
    Lim HE; Pak HN; Ahn JC; Song WH; Kim YH
    Europace; 2006 Dec; 8(12):1051-3. PubMed ID: 17148550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.